McKesson agrees to buy Precision Medicine Group for $2.25 billion

PUBT · 2d ago
McKesson agrees to buy Precision Medicine Group for $2.25 billion
  • McKesson agreed to buy Precision Medicine Group for about USD 2.25 billion.
  • Business will sit in McKesson’s Oncology & Multispecialty segment once the deal closes.
  • Transaction aims to expand clinical research and biopharma commercialization services, including stronger clinical trial execution.
  • Precision Medicine Group provides clinical research and commercialization services to biopharma clients.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202608250800BIZWIRE_USPR_____20260824_BW526382) on August 25, 2026, and is solely responsible for the information contained therein.